Author Index

Search or browse for an author across our entire electronic archive

Search results for: D
Results 141 - 150 of 1402 shown below

  • Damiano, V

    F De Vita, M Orditura, E Matano, R Bianco, C Carlomagno, S Infusino, V Damiano, E Simeone, M R Diadema, E Lieto, P Castellano, S Pepe, S De Placido, G Galizia, N Di Martino, F Ciardiello, G Catalano and A R Bianco

    A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

    advance online publication, 2005-04-26 00:00:00.000;

    doi:10.1038/sj.bjc.6602573

    Abstract | Full article | PDF

  • R Bianco, S Garofalo, R Rosa, V Damiano, T Gelardi, G Daniele, R Marciano, F Ciardiello and G Tortora

    Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs

    advance online publication, 2008-03-04 00:00:00.000;

    doi:10.1038/sj.bjc.6604269

    Abstract | Full article | PDF

  • T Gelardi, R Caputo, V Damiano, G Daniele, S Pepe, F Ciardiello, M Lahn, R Bianco and G Tortora

    Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs

    doi:10.1038/sj.bjc.6604493

    Abstract | Full article | PDF

  • E Matano, P Tagliaferri, A Libroia, V Damiano, A Fabbrocini, S De Lorenzo and A R Bianco

    Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study

    doi:10.1054/bjoc.1999.1139

    Abstract | Full article | PDF

  • Damianovich, D

    D Damianovich, M Adena and N C Tebbutt

    Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis

    advance online publication, 2007-02-06 00:00:00.000;

    doi:10.1038/sj.bjc.6603590

    Abstract | Full article | PDF

  • Dammacco, F

    A Vacca, D Ribatti, L Ruco, F Giacchetta, B Nico, F Quondamatteo, R Ria, M Iurlaro and F Dammacco

    Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas

    doi:10.1038/sj.bjc.6690154

    Abstract | Full article | PDF

  • Dammann, E

    E M Weissinger, K Oettrich, C Evans, H-G Genieser, F Schwede, M Dangers, E Dammann, H-J Kolb, H Mischak, A Ganser and W Kolch

    Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapy

    advance online publication, 2004-06-08 00:00:00.000;

    doi:10.1038/sj.bjc.6601909

    Abstract | Full article | PDF

  • Dampier, K

    K Dampier, E A Hudson, L M Howells, M M Manson, R A Walker and A Gescher

    Differences between human breast cell lines in susceptibility towards growth inhibition by genistein

    doi:10.1054/bjoc.2001.1980

    Abstract | Full article | PDF

  • Damstrup, L

    L Damstrup, S K Kuwada, P J Dempsey, C L Brown, C J Hawkey, H S Poulsen, H S Wiley and R J Coffey

    Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis

    doi:10.1038/sj.bjc.6690456

    Abstract | Full article | PDF

  • M W Pedersen, T Thykjær, T F Ørntoft, L Damstrup and H S Poulsen

    Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line

    doi:10.1054/bjoc.2001.2053

    Abstract | Full article | PDF

  • Dancey, G

    J Shamash, G Dancey, C Barlow, P Wilson, W Ansell and R T D Oliver

    Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding

    advance online publication, 2004-11-30 00:00:00.000;

    doi:10.1038/sj.bjc.6602263

    Abstract | Full article | PDF

  • Dancey, J

    K Dalhoff, J Dancey, L Astrup, T Skovsgaard, K J Hamberg, F J Lofts, O Rosmorduc, S Erlinger, J Bach Hansen, W P Steward, T Skov, F Burcharth and T R J Evans

    A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

    doi:10.1038/sj.bjc.6601104

    Abstract | Full article | PDF

  • C A Townsley, P Major, L L Siu, J Dancey, E Chen, G R Pond, T Nicklee, J Ho, D Hedley, M Tsao, M J Moore and A M Oza

    Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer

    advance online publication, 2006-03-28 00:00:00.000;

    doi:10.1038/sj.bjc.6603055

    Abstract | Full article | PDF

  • I Duran, J Kortmansky, D Singh, H Hirte, W Kocha, G Goss, L Le, A Oza, T Nicklee, J Ho, D Birle, G R Pond, D Arboine, J Dancey, S Aviel-Ronen, M-S Tsao, D Hedley and L L Siu

    A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas

    advance online publication, 2006-10-10 00:00:00.000;

    doi:10.1038/sj.bjc.6603419

    Abstract | Full article | PDF

  • Dancourt, V

    J L Jouve, L Remontet, V Dancourt, C Lejeune, A M Benhamiche, J Faivre and J Esteve

    Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening

    doi:10.1054/bjoc.2001.1752

    Abstract | Full article | PDF

  • Dandrea, M

    A Mercalli, V Sordi, R Formicola, M Dandrea, S Beghelli, A Scarpa, V Di Carlo, M Reni and L Piemonti

    A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer

    advance online publication, 2007-04-10 00:00:00.000;

    doi:10.1038/sj.bjc.6603726

    Abstract | Full article | PDF